he simply referred me to the report and highlighted the impact on future revenues that the historical amount of trials coming to production will have plus the reports coming out on pre infancy studies with over 52 hospitals ..this has been a 7 year wait! plus he is very happy with the increased sales in EMEA and the USA and the securing of patents and cost control., maintaining dividends and the fact that they did not lose ONE customer during the Fonterra SAGA means that orders will return to normality which all looks good for future values
what can we expect from first half fy14 report, page-11
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CLV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.0¢ |
Change
-0.005(1.01%) |
Mkt cap ! $60.11M | |||
| Open | High | Low | Value | Volume |
| 49.0¢ | 49.5¢ | 49.0¢ | $8.983K | 18.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32789 | 49.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 44797 | 1 |
View Market Depth
| Last trade - 15.45pm 15/11/2024 (20 minute delay) ? |
| CLV (ASX) Chart |
